Revolution MD Secures United States Patent for AI-Powered Controlled-Substance Oversight System
KNOXVILLE, Tenn., April 17, 2026 /PRNewswire/ -- Revolution MD, a leader in safe, controlled delivery of high-risk medications like opioids and other controlled substances today announced the issuance of its patent for a groundbreaking global drug delivery monitoring and authorization....
View original →